ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for RGEN

Stock NameRepligen Corporation
TickerRGEN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS7599161095
LEI54930006QJ0T5AUO1E71

Show aggregate RGEN holdings

News associated with RGEN

Repligen Corporation (NASDAQ:RGEN) Receives Average Recommendation of “Moderate Buy” from Analysts
Repligen Corporation (NASDAQ:RGEN – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1 year target price […] - 2025-09-19 03:14:49
Repligen Corporation (NASDAQ:RGEN) Receives $169.45 Average Target Price from Analysts
Repligen Corporation (NASDAQ:RGEN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are presently covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year price target […] - 2025-08-28 03:14:53
Rep. Lisa C. McClain Sells Off Shares of Repligen Corporation (NASDAQ:RGEN)
Representative Lisa C. McClain (R-Michigan) recently sold shares of Repligen Corporation (NASDAQ:RGEN). In a filing disclosed on August 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Repligen stock on June 17th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account. Representative Lisa C. McClain also recently made […] - 2025-08-21 03:08:43
Swiss National Bank Sells 1,500 Shares of Repligen Corporation (NASDAQ:RGEN)
Swiss National Bank decreased its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,200 shares of the biotechnology company’s stock after selling 1,500 shares during the quarter. Swiss […] - 2025-08-15 05:44:53
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. lifted its position in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 4.4% in the first quarter, Holdings Channel reports. The firm owned 3,632 shares of the biotechnology company’s stock after purchasing an additional 152 shares during the period. PNC Financial Services Group Inc.’s holdings in Repligen were worth […] - 2025-08-14 05:32:58
Wealthquest Corp Invests $264,000 in Repligen Corporation (NASDAQ:RGEN)
Wealthquest Corp acquired a new position in Repligen Corporation (NASDAQ:RGEN – Free Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,077 shares of the biotechnology company’s stock, valued at approximately $264,000. Other hedge funds have also recently bought and sold shares of the […] - 2025-08-01 04:44:56
Thornburg Investment Management Inc. Has $4.29 Million Position in Repligen Corporation (NASDAQ:RGEN)
Thornburg Investment Management Inc. trimmed its stake in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 4.7% in the first quarter, Holdings Channel.com reports. The firm owned 33,720 shares of the biotechnology company’s stock after selling 1,646 shares during the quarter. Thornburg Investment Management Inc.’s holdings in Repligen were worth $4,291,000 at the end […] - 2025-07-30 04:44:45
Repligen Corporation (NASDAQ:RGEN) Shares Bought by Signaturefd LLC
Signaturefd LLC raised its position in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 65.3% during the 1st quarter, Holdings Channel reports. The firm owned 324 shares of the biotechnology company’s stock after buying an additional 128 shares during the quarter. Signaturefd LLC’s holdings in Repligen were worth $41,000 as of its most recent […] - 2025-07-24 05:00:47
Ballentine Partners LLC Has $224,000 Stock Holdings in Repligen Corporation (NASDAQ:RGEN)
Ballentine Partners LLC lessened its stake in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 6.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,759 shares of the biotechnology company’s stock after selling 120 shares during the period. […] - 2025-07-17 06:05:50
Allworth Financial LP Sells 733 Shares of Repligen Corporation (NASDAQ:RGEN)
Allworth Financial LP reduced its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 47.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 809 shares of the biotechnology company’s stock after selling 733 shares during the quarter. Allworth Financial LP’s […] - 2025-07-17 05:25:12
Repligen Corporation (NASDAQ:RGEN) Shares Bought by State of Michigan Retirement System
State of Michigan Retirement System grew its holdings in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.8% in the 1st quarter, Holdings Channel reports. The fund owned 12,453 shares of the biotechnology company’s stock after acquiring an additional 100 shares during the period. State of Michigan Retirement System’s holdings in Repligen were worth […] - 2025-07-15 06:28:23
DekaBank Deutsche Girozentrale Decreases Holdings in Repligen Corporation (NASDAQ:RGEN)
DekaBank Deutsche Girozentrale trimmed its holdings in shares of Repligen Corporation (NASDAQ:RGEN – Free Report) by 1.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,750 shares of the biotechnology company’s stock after selling 80 shares during the period. DekaBank Deutsche […] - 2025-07-14 05:34:50
Repligen Corporation (NASDAQ:RGEN) Shares Acquired by Teacher Retirement System of Texas
Teacher Retirement System of Texas grew its holdings in Repligen Corporation (NASDAQ:RGEN – Free Report) by 61.7% during the 1st quarter, HoldingsChannel.com reports. The firm owned 15,811 shares of the biotechnology company’s stock after buying an additional 6,036 shares during the period. Teacher Retirement System of Texas’ holdings in Repligen were worth $2,012,000 at the […] - 2025-07-11 05:50:59
Repligen (NASDAQ:RGEN) Price Target Cut to $130.00 by Analysts at Evercore ISI
Repligen (NASDAQ:RGEN – Free Report) had its target price cut by Evercore ISI from $140.00 to $130.00 in a report issued on Tuesday morning,Benzinga reports. They currently have an in-line rating on the biotechnology company’s stock. A number of other brokerages have also recently issued reports on RGEN. Wall Street Zen cut shares of Repligen […] - 2025-07-11 03:08:46
Principal Financial Group Inc. Boosts Holdings in Repligen Corporation (NASDAQ:RGEN)
Principal Financial Group Inc. grew its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 55.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 186,715 shares of the biotechnology company’s stock after purchasing an additional 66,808 shares during the period. Principal Financial Group Inc.’s holdings in Repligen were worth $23,758,000 at the end […] - 2025-07-09 05:51:35
New York State Teachers Retirement System Has $6.49 Million Stake in Repligen Corporation (NASDAQ:RGEN)
New York State Teachers Retirement System reduced its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 5.4% during the first quarter, HoldingsChannel reports. The firm owned 51,032 shares of the biotechnology company’s stock after selling 2,900 shares during the period. New York State Teachers Retirement System’s holdings in Repligen were worth $6,493,000 at the […] - 2025-07-06 06:14:54
Mirae Asset Global Investments Co. Ltd. Purchases 11,193 Shares of Repligen Corporation (NASDAQ:RGEN)
Mirae Asset Global Investments Co. Ltd. boosted its position in Repligen Corporation (NASDAQ:RGEN – Free Report) by 60.1% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 29,822 shares of the biotechnology company’s stock after purchasing an additional 11,193 shares during the period. Mirae Asset Global Investments […] - 2025-07-02 06:04:50
Retirement Systems of Alabama Acquires 86 Shares of Repligen Corporation (NASDAQ:RGEN)
Retirement Systems of Alabama boosted its holdings in Repligen Corporation (NASDAQ:RGEN – Free Report) by 0.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 63,418 shares of the biotechnology company’s stock after acquiring an additional 86 shares during the period. Retirement […] - 2025-06-24 05:32:52
Analysts Anticipate IYH To Hit $66
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:47:36
Analysts Anticipate IYH To Hit $66
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:47:26
Parallel Advisors LLC Reduces Holdings in Repligen Co. (NASDAQ:RGEN)
Parallel Advisors LLC reduced its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 30.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 285 shares of the biotechnology company’s stock after selling 123 shares during the quarter. Parallel Advisors LLC’s holdings in Repligen were worth $36,000 at the end of the most recent quarter. […] - 2025-06-10 04:46:53
Squarepoint Ops LLC Sells 81,814 Shares of Repligen Co. (NASDAQ:RGEN)
Squarepoint Ops LLC reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 85.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,291 shares of the biotechnology company’s stock after selling 81,814 shares during the quarter. Squarepoint Ops LLC’s holdings in Repligen were worth $2,057,000 as of its most […] - 2025-05-29 05:52:48
ProShare Advisors LLC Has $351,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN)
ProShare Advisors LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 7.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,438 shares of the biotechnology company’s stock after acquiring an additional 167 shares during the period. ProShare Advisors LLC’s […] - 2025-05-29 05:08:49
Tidal Investments LLC Decreases Stock Holdings in Repligen Co. (NASDAQ:RGEN)
Tidal Investments LLC lowered its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 60.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,437 shares of the biotechnology company’s stock after selling 6,712 shares during the period. Tidal […] - 2025-05-28 05:52:53
The Math Shows MDY Can Go To $634
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-22 07:58:15
Repligen Co. (NASDAQ:RGEN) Shares Sold by Bank of America Corp DE
Bank of America Corp DE decreased its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 277,947 shares of the biotechnology company’s stock after selling 158,404 shares during the period. Bank of America […] - 2025-05-16 06:38:55
Financial Survey: Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE)
Repligen (NASDAQ:RGEN – Get Free Report) and Maze Therapeutics (NASDAQ:MAZE – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends and earnings. Analyst Recommendations This is a summary of recent recommendations […] - 2025-05-16 02:09:10
Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright
Repligen (NASDAQ:RGEN – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $180.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would suggest a potential upside of 38.04% from the stock’s previous close. […] - 2025-05-07 02:58:48
Repligen (NASDAQ:RGEN) Given New $190.00 Price Target at JPMorgan Chase & Co.
Repligen (NASDAQ:RGEN – Free Report) had its target price trimmed by JPMorgan Chase & Co. from $200.00 to $190.00 in a research note published on Tuesday morning,Benzinga reports. The firm currently has an overweight rating on the biotechnology company’s stock. RGEN has been the subject of several other reports. Wolfe Research raised shares of Repligen […] - 2025-04-30 05:32:52
Repligen (NASDAQ:RGEN) Upgraded by Wolfe Research to Outperform Rating
Wolfe Research upgraded shares of Repligen (NASDAQ:RGEN – Free Report) from a peer perform rating to an outperform rating in a report published on Tuesday, Marketbeat.com reports. They currently have $160.00 price objective on the biotechnology company’s stock. A number of other research firms have also weighed in on RGEN. Royal Bank of Canada upped […] - 2025-04-30 05:32:47

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc RGEN holdings

DateNumber of RGEN Shares HeldBase Market Value of RGEN SharesLocal Market Value of RGEN SharesChange in RGEN Shares HeldChange in RGEN Base ValueCurrent Price per RGEN Share HeldPrevious Price per RGEN Share Held
2026-01-15 (Thursday)33,509RGEN holding increased by 5148USD 5,418,070RGEN holding increased by 822737USD 5,418,0705,148USD 822,737 USD 161.69 USD 162.03
2026-01-14 (Wednesday)28,361RGEN holding increased by 99USD 4,595,333RGEN holding decreased by -133182USD 4,595,33399USD -133,182 USD 162.03 USD 167.31
2026-01-13 (Tuesday)28,262USD 4,728,515RGEN holding decreased by -30806USD 4,728,5150USD -30,806 USD 167.31 USD 168.4
2026-01-12 (Monday)28,262USD 4,759,321RGEN holding increased by 44654USD 4,759,3210USD 44,654 USD 168.4 USD 166.82
2026-01-09 (Friday)28,262USD 4,714,667RGEN holding increased by 11305USD 4,714,6670USD 11,305 USD 166.82 USD 166.42
2026-01-08 (Thursday)28,262RGEN holding increased by 99USD 4,703,362RGEN holding decreased by -57593USD 4,703,36299USD -57,593 USD 166.42 USD 169.05
2026-01-07 (Wednesday)28,163USD 4,760,955RGEN holding decreased by -90403USD 4,760,9550USD -90,403 USD 169.05 USD 172.26
2026-01-06 (Tuesday)28,163USD 4,851,358RGEN holding increased by 79419USD 4,851,3580USD 79,419 USD 172.26 USD 169.44
2026-01-05 (Monday)28,163USD 4,771,939RGEN holding increased by 143350USD 4,771,9390USD 143,350 USD 169.44 USD 164.35
2026-01-02 (Friday)28,163USD 4,628,589RGEN holding increased by 13800USD 4,628,5890USD 13,800 USD 164.35 USD 163.86
2025-12-31 (Wednesday)28,163USD 4,614,789RGEN holding decreased by -76885USD 4,614,7890USD -76,885 USD 163.86 USD 166.59
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RGEN by Blackrock for IE00B3VWM098

Show aggregate share trades of RGEN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-01-15BUY5,148165.030158.800 159.423USD 820,710 142.89
2026-01-14BUY99168.250158.910 159.844USD 15,825 142.81
2026-01-08BUY99168.660164.230 164.673USD 16,303 142.40
2025-12-23SELL-99166.970162.530 162.974USD -16,134 141.32 Loss of -2,144 on sale
2025-12-03SELL-495170.400165.040 165.576USD -81,960 139.98 Loss of -12,669 on sale
2025-12-02BUY198168.280163.230 163.735USD 32,420 139.86
2025-11-25SELL-297173.645167.105 167.759USD -49,824 139.13 Loss of -8,503 on sale
2025-11-24SELL-297167.970160.650 161.382USD -47,930 138.99 Loss of -6,650 on sale
2025-11-17SELL-1,089154.820148.450 149.087USD -162,356 138.60 Loss of -11,422 on sale
2025-11-12SELL-99158.740152.620 153.232USD -15,170 138.37 Loss of -1,471 on sale
2025-11-06SELL-99147.000141.630 142.167USD -14,075 138.20 Loss of -393 on sale
2025-11-05SELL-990148.650144.020 144.483USD -143,038 138.16 Loss of -6,261 on sale
2025-11-04SELL-198151.250146.000 146.525USD -29,012 138.11 Loss of -1,666 on sale
2025-11-03SELL-198150.820146.535 146.964USD -29,099 138.05 Loss of -1,765 on sale
2025-10-28BUY297151.570166.620 165.115USD 49,039 137.83
2025-10-24SELL-99166.330169.870 169.516USD -16,782 137.55 Loss of -3,165 on sale
2025-10-15BUY594149.520152.360 152.076USD 90,333 136.83
2025-10-02BUY99145.230148.480 148.155USD 14,667 136.72
2025-09-30BUY198133.670134.090 134.048USD 26,542 136.68
2025-09-11BUY396119.510122.710 122.390USD 48,466 137.11
2025-08-21SELL-105119.650121.440 121.261USD -12,732 137.22 Profit of 1,675 on sale
2025-07-31BUY315117.070122.730 122.164USD 38,482 137.43
2025-07-28SELL-105119.650121.730 121.522USD -12,760 137.71 Profit of 1,699 on sale
2025-07-07BUY742124.430127.450 127.148USD 94,344 138.96
2025-06-30SELL-206124.380126.040 125.874USD -25,930 139.39 Profit of 2,784 on sale
2025-06-25SELL-103124.020126.610 126.351USD -13,014 139.71 Profit of 1,376 on sale
2025-06-20SELL-206118.850120.770 120.578USD -24,839 140.12 Profit of 4,025 on sale
2025-05-23BUY103118.150118.900 118.825USD 12,239 142.78
2025-05-19SELL-103126.190126.380 126.361USD -13,015 143.44 Profit of 1,760 on sale
2025-05-15SELL-309123.260128.340 127.832USD -39,500 143.77 Profit of 4,925 on sale
2025-05-12SELL-103133.720134.060 134.026USD -13,805 144.11 Profit of 1,039 on sale
2025-05-09SELL-103123.240130.870 130.107USD -13,401 144.30 Profit of 1,462 on sale
2025-04-30SELL-103137.990139.540 139.385USD -14,357 144.96 Profit of 574 on sale
2025-04-24SELL-206145.230145.910 145.842USD -30,043 145.02 Loss of -169 on sale
2025-04-17SELL-103130.000131.510 131.359USD -13,530 145.59 Profit of 1,466 on sale
2025-04-15SELL-309126.620130.310 129.941USD -40,152 145.94 Profit of 4,944 on sale
2025-04-14SELL-309127.260128.930 128.763USD -39,788 146.15 Profit of 5,372 on sale
2025-04-09SELL-412123.850124.380 124.327USD -51,223 147.02 Profit of 9,348 on sale
2025-04-07SELL-721116.110121.840 121.267USD -87,434 147.82 Profit of 19,145 on sale
2025-04-04SELL-1,030111.940118.420 117.772USD -121,305 148.24 Profit of 31,384 on sale
2025-03-31BUY103127.240131.160 130.768USD 13,469 148.95
2025-03-19SELL-206144.880146.600 146.428USD -30,164 149.90 Profit of 715 on sale
2025-03-17BUY657152.810153.890 153.782USD 101,035 149.94
2025-03-14SELL-600150.620150.870 150.845USD -90,507 149.93 Loss of -551 on sale
2025-03-13SELL-202142.440146.650 146.229USD -29,538 150.03 Profit of 769 on sale
2025-03-12SELL-3,434145.370149.660 149.231USD -512,459 150.10 Profit of 2,991 on sale
2025-03-07SELL-202155.700161.680 161.082USD -32,539 150.26 Loss of -2,186 on sale
2025-03-06SELL-303160.110163.780 163.413USD -49,514 150.11 Loss of -4,031 on sale
2025-03-03SELL-101155.380160.990 160.429USD -16,203 149.83 Loss of -1,071 on sale
2025-02-28BUY2,600159.260160.050 159.971USD 415,925 149.67
2025-02-26SELL-92162.810165.820 165.519USD -15,228 149.33 Loss of -1,489 on sale
2025-02-25SELL-276161.470165.470 165.070USD -45,559 149.12 Loss of -4,401 on sale
2025-02-18BUY460145.180149.040 148.654USD 68,381 148.43
2025-02-13BUY92146.170148.450 148.222USD 13,636 148.54
2025-02-12BUY92145.720148.260 148.006USD 13,617 148.59
2025-02-11BUY276149.490154.480 153.981USD 42,499 148.58
2025-02-06BUY828161.860163.700 163.516USD 135,391 148.00
2025-01-27BUY92168.010168.230 168.208USD 15,475 144.13
2024-12-30BUY460143.810145.030 144.908USD 66,658 142.79
2024-12-06BUY368149.200150.560 150.424USD 55,356 141.87
2024-12-05BUY92142.260148.170 147.579USD 13,577 141.86
2024-12-04BUY460149.090150.780 150.611USD 69,281 141.60
2024-11-29BUY460150.540150.790 150.765USD 69,352 140.61
2024-11-27BUY368149.990150.700 150.629USD 55,431 139.80
2024-11-26BUY92146.740147.050 147.019USD 13,526 139.48
2024-11-25BUY4,119146.060148.030 147.833USD 608,924 139.17
2024-11-21BUY400141.760142.110 142.075USD 56,830 138.85
2024-11-20BUY240138.900139.200 139.170USD 33,401 138.85
2024-11-18BUY960123.410126.250 125.966USD 120,927 140.46
2024-11-12BUY640148.590154.480 153.891USD 98,490 139.92
2024-11-08BUY400140.700143.270 143.013USD 57,205 139.86
2024-11-07BUY1,200143.880146.350 146.103USD 175,324 139.55
2024-11-06BUY160145.930150.780 150.295USD 24,047 139.02
2024-10-31BUY80134.270137.500 137.177USD 10,974 138.74
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RGEN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19184,8300275,18767.2%
2025-09-18149,326150235,41163.4%
2025-09-17244,2100450,06254.3%
2025-09-16244,8040507,88348.2%
2025-09-1582,951200234,57635.4%
2025-09-12106,2140244,49443.4%
2025-09-1189,32813192,44246.4%
2025-09-10178,6915413,00343.3%
2025-09-0970,869300226,62931.3%
2025-09-08120,724301294,13341.0%
2025-09-05226,84279378,40359.9%
2025-09-04146,7760331,18244.3%
2025-09-0399,82871193,76451.5%
2025-09-0284,4330164,31051.4%
2025-08-2991,080373217,77041.8%
2025-08-28141,6900402,89835.2%
2025-08-2740,5357145,81927.8%
2025-08-2674,674814199,53837.4%
2025-08-2560,55788144,20642.0%
2025-08-22123,02724289,12642.6%
2025-08-2188,53618155,76856.8%
2025-08-2092,1092192,27247.9%
2025-08-19126,38215253,04149.9%
2025-08-1889,3780179,19049.9%
2025-08-15128,4545231,97655.4%
2025-08-14174,5483296,57858.9%
2025-08-13115,929481251,93546.0%
2025-08-12156,45720400,25839.1%
2025-08-1194,4552,643220,58542.8%
2025-08-0881,3830276,03729.5%
2025-08-0773,5050260,65928.2%
2025-08-06119,5340512,18923.3%
2025-08-0578,097169261,75729.8%
2025-08-0476,311741262,10129.1%
2025-08-01156,1670408,79838.2%
2025-07-31171,9375403,96642.6%
2025-07-30208,5310613,29734.0%
2025-07-29329,89441,013,56432.5%
2025-07-28132,6333,387367,56436.1%
2025-07-25113,2590346,38232.7%
2025-07-24187,6010365,36151.3%
2025-07-23177,6200666,40226.7%
2025-07-22269,18928,300659,38140.8%
2025-07-21144,183270582,43224.8%
2025-07-18155,435769451,13934.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy